ArticleAnnals of medicine2026
Development and validation of a nomogram for predicting the probability of arthroplasty in patients with osteonecrosis of the femoral head after fibular strut grafting.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile fibular strut grafting (FSG) is effective for osteonecrosis of the femoral head (ONFH), some patients still progress to total hip arthroplasty (THA). This study aimed to identify risk factors for FSG failure and develop a validated nomogram to predict the mid-long term survival rate after FSG.
methodsData on patients with ONFH who underwent FSG were collected in our institution from February 2009 to December 2018. Independent predictors were identified using univariable and multivariable Cox regression analyses. Kaplan-Meier analysis was used to estimate survival after FSG. A nomogram predicting failure, defined as conversion to THA, was developed from the selected predictors and internally validated using the concordance index (C index), the Receiver Operating characteristic (ROC) curves, and calibration curves.
resultsAmong 416 eligible patients, 55 converted to THA. The 5-, 8-, and 10-year survival rates after FSG were 89.7%, 83.6%, and 82%, respectively. Age, smoking, Fibrinogen (FIB), hypertension, diabetes, and ARCO stage were independent predictors of failure. Subsequently, a nomogram model was developed incorporating 7 predictors (including JIC classification). Its C-index was 0.734 (95%CI 0.66-0.80). The area under the curves (AUCs) of the nomogram predicted for 5-, 8-, and 10-year were 0.727, 0.735, and 0.735, respectively. Predicted and observed survival rates agreed closely.
conclusionThe internal validation shows that the nomogram model has acceptable discriminative ability and good accuracy. It may support clinical application, effectively optimize perioperative management, and help doctors and patients to avoid FSG failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.